{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:37:14Z","timestamp":1790397434353,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.purol.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T08:29:55Z","timestamp":1466670595000},"page":"437-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Int\u00e9r\u00eat de l\u2019association amoxicilline\u2013acide clavulanique en urologie\u00a0: mise au point"],"prefix":"10.1016","volume":"26","author":[{"given":"F.","family":"Bruy\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dihn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2016.05.002_bib0005","unstructured":"EAU-Guidelines-Urological-Infections-v2.pdf. at http:\/\/uroweb.org\/wp-content\/uploads\/EAU-Guidelines-Urological-Infections-v2.pdf."},{"key":"10.1016\/j.purol.2016.05.002_bib0010","unstructured":"2013\u00a0Surgical Prophylaxis ASHP, IDSA, SHEA, SIS(1).pdf. at http:\/\/www.idsociety.org\/uploadedFiles\/IDSA\/Guidelines-Patient_Care\/PDF_Library\/2013\u00a0%20Surgical%20Prophylaxis%20ASHP,%20IDSA,%20SHEA,%20SIS(1).pdf."},{"issue":"8","key":"10.1016\/j.purol.2016.05.002_bib0015","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.293.8.949","article-title":"Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial","volume":"293","author":"Hooton","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.purol.2016.05.002_bib0020","unstructured":"SPILF 2014-2014-infections_urinaires-long.pdf. at http:\/\/www.infectiologie.com\/site\/medias\/Recos\/2014-infections_urinaires-long.pdf"},{"key":"10.1016\/j.purol.2016.05.002_bib0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/j.1875-9114.1984.tb03333.x","article-title":"Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects","volume":"4","author":"Weber","year":"1984","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.purol.2016.05.002_bib0030","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.ijantimicag.2007.07.037","article-title":"The clinical development and launch of amoxicillin\/clavulanate for the treatment of a range of community-acquired infections","volume":"2","author":"Ball","year":"2007","journal-title":"Int J Antimicrob Agents 30\u00a0Suppl"},{"key":"10.1016\/j.purol.2016.05.002_bib0035","first-page":"591","article-title":"Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination","volume":"3","author":"Stein","year":"1984","journal-title":"Clin Pharm"},{"key":"10.1016\/j.purol.2016.05.002_bib0040","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(80)91118-6","article-title":"Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study","volume":"1","author":"Ball","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.purol.2016.05.002_bib0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0399-077X(14)70302-6","article-title":"P-13: surveillance des souches d\u2019Escherichia coli productrices de b\u00eata-lactamases \u00e0 spectre \u00e9tendu (BLSE) isol\u00e9es en milieu communautaire de 2008\u00a0\u00e0 2013 (MedQual)","volume":"44","author":"Thibaut","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.purol.2016.05.002_bib0050","unstructured":"CASFM_EUCAST_V1_0_2014(1).pdf. at http:\/\/www.sfm-microbiologie.org\/UserFiles\/files\/casfm\/CASFM_EUCAST_V1_0_2014(1).pdf"},{"key":"10.1016\/j.purol.2016.05.002_bib0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/dkg312","article-title":"European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria","volume":"52","author":"Kahlmeter","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.purol.2016.05.002_bib0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000074526","article-title":"Penetration of antimicrobial agents into the prostate","volume":"49","author":"Charalabopoulos","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.purol.2016.05.002_bib0065","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.clinthera.2005.07.001","volume":"27","author":"Ponte","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.purol.2016.05.002_bib0070","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/j.1552-4604.1984.tb01818.x","article-title":"Pharmacokinetics and urinary excretion of clavulanic acid after oral administration of amoxicillin and potassium clavulanate","volume":"24","author":"Ferslew","year":"1984","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.purol.2016.05.002_bib0075","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2125.1988.tb03395.x","article-title":"Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin","volume":"26","author":"Davies","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.purol.2016.05.002_bib0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/1120009X.1990.11739013","article-title":"Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man","volume":"2","author":"Fraschini","year":"1990","journal-title":"J Chemother"},{"key":"10.1016\/j.purol.2016.05.002_bib0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0163-4453(86)94164-2","article-title":"Augmentin (amoxycillin-clavulanic acid) compared with amoxycillin alone in the treatment of urinary tract infections in the elderly","volume":"12","author":"Gallacher","year":"1986","journal-title":"J Infect"},{"key":"10.1016\/j.purol.2016.05.002_bib0090","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/AAC.20.6.800","article-title":"Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin","volume":"20","author":"Martinelli","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.purol.2016.05.002_bib0095","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.22.4.672","article-title":"Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid","volume":"22","author":"Iravani","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.purol.2016.05.002_bib0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/7.3.229","article-title":"Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria","volume":"7","author":"Leigh","year":"1981","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.purol.2016.05.002_bib0105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1128\/AAC.22.2.346","article-title":"Activities of amoxicillin and clavulanic acid combinations against urinary tract infections","volume":"22","author":"Crokaert","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.purol.2016.05.002_bib0110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jac\/5.6.705","article-title":"Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections","volume":"5","author":"Goldstein","year":"1979","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.purol.2016.05.002_bib0115","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.24.5.716","article-title":"Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections","volume":"24","author":"Gurwith","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.purol.2016.05.002_bib0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.289.6437.82","article-title":"Augmentin (amoxycillin-clavulanic acid) compared with co-trimoxazole in urinary tract infections","volume":"289","author":"Fancourt","year":"1984","journal-title":"Br Med J Clin Res Ed"},{"key":"10.1016\/j.purol.2016.05.002_bib0125","first-page":"970","article-title":"Comparison of augmentin with co-trimoxazole for treatment of uncomplicated urinary tract infections","volume":"96","author":"Bailey","year":"1983","journal-title":"N Z Med J"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S116670871630032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S116670871630032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:27:40Z","timestamp":1761114460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S116670871630032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S116670871630032X"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2016.05.002","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Int\u00e9r\u00eat de l\u2019association amoxicilline\u2013acide clavulanique en urologie\u00a0: mise au point","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}